Navigation Links
Normal-looking sperm may have serious damage; scientists urge more care in selection
Date:7/8/2008

on by fluorescence microscopy. The sperm morphology was evaluated in 400 randomly selected cells per sample. When a sperm with normal morphology was found, the light was switched to fluorescence to determine DNA integrity. Sperm with normal morphology from the fertile group showed no evidence of DNA fragmentation. But in the infertile men, between 20 and 66% of normal-looking sperm had DNA damage.

"The origin of DNA fragmentation can be multi factorial," said Mr. Avendao. "Oxidative stress (mainly due to reproductive tract infections) and apoptosis are the most studied, but other factors as age, smoking, exposure to air pollution and abnormal testicular warming are believed to increase the proportion of sperm DNA fragmentation."

The researchers are now applying DNA fragmentation evaluation to couples with male factor infertility. "Our preliminary results using this new evaluation method show a clear negative correlation between the percentage of DNA fragmented sperm and the embryo quality and pregnancy outcome," said Mr. Avendao.

"Different research groups have shown that in addition to affecting normal embryonic development, fertilisation with damaged spermatozoa resulting in a live-born infant can be associated with increased chromosomal abnormalities, minor or major birth defects, and even childhood cancer," said Mr. Avendao. "Our work has shown that normal sperm morphology alone should not be used as the unique attribute for the selection of sperm for ICSI. New methods that allow an accurate separation of sperm with intact DNA should be sought."

Sperm biology has received less attention since the introduction and success of the ICSI technique, say the researchers. "While the ICSI procedure bypasses the natural sperm selection, we believe that the deleterious effects of injecting a DNA-fragmented sperm should and can be avoided. Further research into sperm biology is essential if we are to avoid problems in the future," said
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
34-932-308-810
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Wiggle room: Cornell researcher borrows idea from sperm to provide energy for nanoscale robots
2. Mutant sperm guide clinicians to new diseases
3. Primate sperm competition: speed matters
4. Bacterial slime helps cause serious disease
5. Oceanic sharks worldwide at serious risk from high-seas fishing, rising demand for shark products
6. West Nile virus spread through nerve cells linked to serious complication
7. Study finds blocking angiogenesis signaling from inside cell may lead to serious health problems
8. Biodiversity maps developed by UCSD scientists will help guide conservation measures in East Africa
9. Scientists integrate data in three dimensions to study climate effects on young fish
10. Scientists set out to measure how we perceive naturalness
11. Scientists reveal the key mechanisms for affinity between transient binding proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... market announces a revised version of one of its first 30 ... on CNBC in New York , ... San Francisco metro areas.    , ... to replace all the cards in your wallet and keep your ...
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... MD August 16, 2011 Maurice Godfrey, PhD, ... the University of Nebraska Medical Center, was recently awarded ... Genetics (ASHG) for his proposal titled, "Luck of the ... funded through the Society,s 2011 Genetics Education Research Program. ...
... -- Today, oxygen takes up a hefty portion of Earth,s ... air we breathe. However, very early in Earth,s history, O2 ... in the turbulent mix of primordial gases. It wasn,t until ... when oxygen made any measurable dent in the atmosphere, stimulating ...
... August 16, 2011To overcome the unique challenges faced by ... color who have sex with men (YMSM of Color)novel ... prevention services were recently evaluated. The innovative outreach and ... are presented in a special supplement issue of ...
Cached Biology News:MIT: Oxygen's watery past 2MIT: Oxygen's watery past 3
(Date:7/28/2015)... 29, 2015 A ... rapidly developing and commercialising innovative medicines to transform ... Highly experienced management team; blue chip ... Mereo BioPharma Group Ltd ("Mereo"), a recently-formed speciality ... c. £76.5m), gross, from blue chip institutional investors and ...
(Date:7/28/2015)... , July 28, 2015 Seahorse ... cell metabolism, is the provider of XF Technology ... all disease research areas. As the links between ... into cell metabolism is escalating rapidly.   ... by the Nature Publishing Group (NPG) featuring XF ...
(Date:7/28/2015)... -- Deerfield Management Company, L.P. today announced the launch ... invest in groundbreaking advancements in science that may lead ... diseases. The venture capital fund will also back new ... improve the way healthcare is delivered to patients. ... funds in the sector, will donate all profits not ...
(Date:7/28/2015)... Pa. , July 28, 2015 ... and Drug Administration has accepted for review the company,s ... factor VIII single-chain (rVIII-SingleChain) for the treatment of hemophilia ... primary endpoints. Hemophilia A ... defective factor VIII; nearly all affected patients are male. ...
Breaking Biology Technology:Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... - Researchers are making progress in creating digital transistors ... thought to dramatically limit the material,s use in computers ... of carbon that conducts electricity with little resistance or ... earned a Nobel Prize in physics - it was ...
... was named by FierceBiotech today as one of 2011,s ... promising private biotechnology companies in the industry. This is FierceBiotech,s ... has done a super job of raising the funds and ... combination therapy – toward the market," says Ryan McBride, the ...
... Wash. and VANCOUVER, British Columbia, Sept. 6, 2011 ... today that data from two studies, a Phase II ... compound custirsen (OGX-011/TV-1011), were published in the September issues ... Cancer Research . Custirsen inhibits ...
Cached Biology Technology:Innovation is step toward digital graphene transistors 2FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 2FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech 3OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals 2OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals 3OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals 4OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals 5
... Upright Freezer Inventory Storage Racks ... configurations available to fit all makes ... refrigerators. Made of high quality ... 3" high fiberboard, stainless steel or ...
Chlorine-36, 3.7 MBq, 100 uCi. 0.1-0.3 HCl.< 111 MBq/g Cl, < 3 mCi/g Cl.Dispensed to order. Please inquire for alternative pack sizes. Category: Radiochemicals &Radiation Safety, Radiochemicals....
...
...
Biology Products: